Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 5304 | 139 | 0.2615 | 0.2652 | 0.0262 | 0.0225 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 7790 | 111 | 0.3888 | 0.4180 | 0.0142 | 0.0173 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 5737 | 112 | 0.2848 | 0.2652 | 0.0195 | 0.0225 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20251 | 1109 | 1.0021 | 1.0000 | 0.0548 | 0.0527 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8744 | 163 | 0.4345 | 0.4180 | 0.0186 | 0.0173 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 3779 | 175 | 0.1727 | 0.1741 | 0.0463 | 0.0433 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 7818 | 140 | 0.4019 | 0.4364 | 0.0179 | 0.0207 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 7190 | 141 | 0.4434 | 0.4477 | 0.0196 | 0.0178 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 8666 | 164 | 0.4305 | 0.4180 | 0.0189 | 0.0173 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 22233 | 990 | 1.0180 | 1.0000 | 0.0445 | 0.0468 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 21096 | 999 | 0.9631 | 1.0000 | 0.0474 | 0.0468 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 22342 | 1082 | 1.0188 | 1.0000 | 0.0484 | 0.0468 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20940 | 1098 | 1.0048 | 1.0000 | 0.0524 | 0.0504 |
A-375 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 2887 | 241 | 0.1268 | 0.1293 | 0.0835 | 0.0864 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 1 | 7134 | 125 | 0.4409 | 0.4477 | 0.0175 | 0.0178 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 3 | 4768 | 111 | 0.2929 | 0.2659 | 0.0233 | 0.0217 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 3676 | 151 | 0.1689 | 0.1741 | 0.0411 | 0.0433 |
A-375 | Vemurafenib | JNK-IN-8 | 1.000 | 0.000 | uM | 72 | hr | 2 | 3545 | 130 | 0.2148 | 0.2091 | 0.0367 | 0.0362 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 3957 | 137 | 0.1934 | 0.1953 | 0.0346 | 0.0349 |
A-375 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 1 | 2723 | 183 | 0.1598 | 0.1658 | 0.0672 | 0.0732 |
A-375 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 2966 | 270 | 0.1292 | 0.1293 | 0.0910 | 0.0864 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 13441 | 248 | 0.6323 | 0.4565 | 0.0185 | 0.0200 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8056 | 164 | 0.3782 | 0.4565 | 0.0204 | 0.0200 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 2950 | 229 | 0.1424 | 0.1538 | 0.0776 | 0.0753 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 3197 | 255 | 0.1540 | 0.1538 | 0.0798 | 0.0753 |